National Notifiable Diseases Surveillance System, 1 April to 30 June 2014

The National Notifiable Diseases Surveillance System collates data from Australian states and territories. These data have been published on the Department of Health website and quarterly data are published in Communicable Diseases Intelligence. This page contains data for the second quarter of 2014.

Page last updated: 07 November 2014

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 54,644 notifications to the National Notifiable Diseases Surveillance System (NNDSS) with a notification received date between 1 April to 30 June 2014 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Table 1: Reporting of notifiable diseases by jurisdiction
Disease Data received from:
* Infections with Shiga-like toxin (verotoxin) producing Escherichia coli (STEC/VTEC).

NEC Not elsewhere classified.
Bloodborne diseases
Hepatitis (NEC)
 All jurisdictions
Hepatitis B (newly acquired)
 All jurisdictions
Hepatitis B (unspecified)
 All jurisdictions
Hepatitis C (newly acquired)
 All jurisdictions except Queensland
Hepatitis C (unspecified)
 All jurisdictions
Hepatitis D
 All jurisdictions
Gastrointestinal diseases
Botulism
 All jurisdictions
Campylobacteriosis
 All jurisdictions except New South Wales
Cryptosporidiosis
 All jurisdictions
Haemolytic uraemic syndrome
 All jurisdictions
Hepatitis A
 All jurisdictions
Hepatitis E
 All jurisdictions
Listeriosis
 All jurisdictions
STEC, VTEC*
 All jurisdictions
Salmonellosis
 All jurisdictions
Shigellosis
 All jurisdictions
Typhoid
 All jurisdictions
Quarantinable diseases
Cholera
 All jurisdictions
Highly pathogenic avian influenza in humans
 All jurisdictions
Plague
 All jurisdictions
Rabies
 All jurisdictions
Severe acute respiratory syndrome
 All jurisdictions
Smallpox
 All jurisdictions
Viral haemorrhagic fever
 All jurisdictions
Yellow fever
 All jurisdictions
Sexually transmissible infections
Chlamydial infection
 All jurisdictions
Donovanosis
 All jurisdictions
Gonococcal infection
 All jurisdictions
Syphilis - congenital
 All jurisdictions
Syphilis < 2 years duration
 All jurisdictions
Syphilis > 2 years or unspecified duration
 All jurisdictions
Vaccine preventable diseases
Diphtheria
 All jurisdictions
Haemophilus influenzae type b
 All jurisdictions
Influenza (laboratory confirmed)
 All jurisdictions
Measles
 All jurisdictions
Mumps
 All jurisdictions
Pertussis
 All jurisdictions
Pneumococcal disease (invasive)
 All jurisdictions
Poliomyelitis
 All jurisdictions
Rubella
 All jurisdictions
Rubella - congenital
 All jurisdictions
Tetanus
 All jurisdictions
Varicella zoster (chickenpox)
 All jurisdictions except New South Wales
Varicella zoster (shingles)
 All jurisdictions except New South Wales
Varicella zoster (unspecified)
 All jurisdictions except New South Wales
Vectorborne diseases
Arbovirus infection (NEC)
 All jurisdictions
Barmah Forest virus infection
 All jurisdictions
Dengue virus infection
 All jurisdictions
Japanese encephalitis virus infection
 All jurisdictions
Kunjin virus infection
 All jurisdictions
Malaria
 All jurisdictions
Murray Valley encephalitis virus infection
 All jurisdictions
Ross River virus infection
 All jurisdictions
Zoonoses
Anthrax
 All jurisdictions
Australian bat lyssavirus
 All jurisdictions
Brucellosis
 All jurisdictions
Leptospirosis
 All jurisdictions
Lyssavirus (NEC)
 All jurisdictions
Ornithosis
 All jurisdictions
Q fever
 All jurisdictions
Tularaemia
 All jurisdictions
Other bacterial infections
Legionellosis
 All jurisdictions
Leprosy
 All jurisdictions
Meningococcal infection
 All jurisdictions
Tuberculosis
 All jurisdictions

Top of page

Table 2: Notifications of diseases received by state and territory health authorities, 1 April to 30 June 2014, by date of diagnosis*
State or territory Total 2nd quarter 2014 Total 1st quarter 2013 Total 2nd quarter 2013 Last 5 years mean 2nd quarter Ratio Year to date 2014 Last 5 years YTD mean
Disease ACT NSW NT Qld SA Tas Vic WA
* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis   unspecified.

‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

§ Infection with Shiga toxin/verotoxin-producing Escherichia coli.

|| Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens. From 1 July 2013 case definition changed to exclude all ocular infections.

¶ The national case definitions for chlamydial, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

** In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

†† Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NN Not notifiable

NEC Not elsewhere classified

Totals comprise data from all states and territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.
Bloodborne diseases
Hepatitis (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Hepatitis B (newly acquired)†
1
11
2
9
0
0
14
7
44
58
43
50.6
0.9
102
106.2
Hepatitis B (unspecified)‡
26
631
46
239
97
20
458
137
1,654
1,644
1,765
1,669.4
1.0
3,283
3,374.6
Hepatitis C (newly acquired)†
6
5
1
0
11
4
30
44
101
98
78
105.6
1.0
199
216.8
Hepatitis C (unspecified)‡
44
890
47
663
99
61
518
256
2,578
2,515
2,494
2,553.0
1.0
5,066
5,168.0
Hepatitis D
0
5
0
4
0
0
4
0
13
10
17
11.4
1.1
23
21.2
Gastrointestinal diseases
Botulism
0
0
0
1
0
0
0
0
1
0
1
0.4
2.5
1
1.0
Campylobacteriosis
134
NN
70
1,492
413
194
1,624
722
4,649
4,816
3,202
3,546.6
1.3
9,415
7,849.8
Cryptosporidiosis
4
91
22
210
68
10
173
87
665
869
1,124
813.2
0.8
1,523
2,253.2
Haemolytic uraemic syndrome
0
1
1
1
0
0
1
0
4
9
3
3.4
1.2
13
7.8
Hepatitis A
1
13
0
8
0
0
16
2
40
86
42
65.2
0.6
125
130.6
Hepatitis E
1
17
0
1
0
0
1
0
20
10
5
8.6
2.3
30
22.4
Listeriosis
0
8
0
2
2
0
8
0
20
22
17
18.0
1.1
42
45.2
STEC, VTEC§
0
9
0
9
11
0
3
0
32
41
29
20.2
1.6
73
56.0
Salmonellosis
71
1,063
145
1,311
327
42
890
353
4,202
5,260
3,016
2,633.6
1.6
9,403
6,685.2
Shigellosis
1
31
24
35
3
0
110
15
219
324
114
124.8
1.8
538
299.2
Typhoid
0
10
1
1
1
0
4
4
21
45
29
24.4
0.9
65
74.0
Quarantinable diseases
Cholera
0
0
0
0
0
0
1
0
1
1
1
2.0
0.5
2
2.6
Highly pathogenic avian influenza in humans
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Plague
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rabies
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Severe acute respiratory syndrome
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Smallpox
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Viral haemorrhagic fever
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Yellow fever
0
0
0
0
0
0
0
0
0
0
0
0.7
0.0
0
0.7
Sexually transmissible infections
Chlamydial infection||,¶
305
5,661
792
5,089
1,410
483
4,827
2,832
21,399
22,686
20,771
19,414.2
1.1
43,946
39,218.2
Donovanosis
0
0
0
0
0
0
0
0
0
0
0
0.2
0.0
0
0.2
Gonococcal infection
28
1,219
494
743
220
11
698
552
3,965
4,293
3,868
3,069.2
1.3
8,206
6,094.4
Syphilis – congenital
0
0
0
0
0
0
0
0
0
0
2
0.8
0.0
0
2.2
Syphilis < 2 years duration
5
146
13
96
5
3
145
32
445
446
411
353.6
1.3
885
715.6
Syphilis > 2 years or unspecified duration‡,¶
9
95
10
60
30
3
226
12
445
480
459
374.0
1.2
919
713.0
Vaccine preventable diseases
Diphtheria
0
0
0
0
0
0
0
0
0
0
0
0.8
0.0
0
1.0
Haemophilus influenzae type b
0
2
0
2
0
0
1
1
6
3
5
5.8
1.0
9
9.6
Influenza (laboratory confirmed)
68
1,023
48
1,480
507
81
880
480
4,567
3,867
2,505
5,980.4
0.8
8,391
7,421.6
Measles
0
7
1
32
5
0
17
10
72
175
17
20.8
3.5
247
58.8
Mumps
1
16
0
15
1
1
3
2
39
64
62
48.0
0.8
102
93.0
Pertussis
45
418
18
327
104
15
769
372
2,068
2,357
2,545
5,829.0
0.4
4,396
12,998.4
Pneumococcal disease (invasive)
4
129
7
57
29
12
107
52
397
217
439
463.2
0.9
611
679.4
Poliomyelitis
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rubella
0
2
0
1
0
0
0
0
3
6
7
9.8
0.3
9
22.0
Rubella – congenital
0
0
0
0
0
0
0
0
0
0
1
0.2
0.0
0
0.2
Tetanus
0
0
0
0
0
0
0
0
0
1
1
0.6
0.0
1
2.4
Varicella zoster (chickenpox)
7
NN
23
35
77
6
194
119
461
484
434
430.6
1.1
940
803.4
Varicella zoster (shingles)
15
NN
58
11
470
67
377
330
1,328
1,414
1,277
958.8
1.4
2,726
1,926.6
Varicella zoster (unspecified)
64
NN
1
1,280
61
28
845
289
2,568
2,783
2,224
1,882.6
1.4
5,326
3,795.8
Vectorborne diseases
Arbovirus infection (NEC)
0
2
0
7
0
0
1
0
10
14
5
3.0
3.3
24
6.4
Barmah Forest virus infection
0
59
12
126
0
0
3
14
214
335
1,561
605.4
0.4
545
1,351.8
Dengue virus infection
8
119
18
103
21
6
5
135
415
656
503
302.4
1.4
1,069
847.4
Japanese encephalitis virus infection
0
0
0
0
0
0
0
0
0
0
2
0.4
0.0
0
0.6
Kunjin virus infection**
0
0
0
0
0
0
0
0
0
0
0
0.4
0.0
0
1.0
Malaria
3
29
1
21
2
1
3
15
75
91
86
96.0
0.8
166
206.8
Murray Valley encephalitis virus infection**
0
0
0
0
0
0
0
0
0
0
0
1.8
0.0
0
4.0
Ross River virus infection
2
211
97
691
15
4
25
254
1,299
1,639
1,314
1,378.6
0.9
2,925
3,366.0
Zoonoses
Anthrax
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.2
Australian bat lyssavirus
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.2
Brucellosis
0
2
0
0
0
0
1
0
3
6
3
5.8
0.5
9
12.8
Leptospirosis
0
1
0
28
0
0
0
1
30
27
33
43.6
0.7
57
97.8
Lyssavirus (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Ornithosis
0
2
0
0
0
0
3
0
5
11
16
15.4
0.3
16
29.4
Q fever
0
34
0
66
5
0
3
2
110
129
138
96.0
1.1
237
191.2
Tularaemia
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.3
Other bacterial infections
Legionellosis
0
19
1
19
11
2
34
22
108
90
111
97.4
1.1
195
178.8
Leprosy
0
0
0
1
0
0
1
2
4
3
4
2.8
1.4
7
4.0
Meningococcal infection††
1
13
0
11
4
0
6
6
41
26
27
53.8
0.8
67
98.2
Tuberculosis
5
101
6
34
10
0
117
30
303
321
289
281.2
1.1
619
598.6
Total
859
12,095
1,959
14,321
4,019
1,054
13,146
7,191
54,644
58,432
51,100
112,553

Top of page

Table 3: Notification rates of diseases, 1 April to 30 June 2014, by state or territory. (Annualised rate per 100,000 population)*,†
Disease State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Rate per 100,000 of population. Annualisation Factor was 4.0

‡ Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis C unspecified.

§ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

|| Infection with Shiga toxin/verotoxin-producing Escherichia coli.

¶ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens. From 1 July 2013 case definition changed to exclude all ocular infections.

** The national case definitions for chlamydial, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

†† In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

‡‡ Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NEC Not elsewhere classified.

NN Not notifiable.
Bloodborne diseases
Hepatitis (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Hepatitis B (newly acquired)‡
1.0
0.6
3.3
0.8
0.0
0.0
1.0
1.1
0.8
Hepatitis B (unspecified)§
27.3
34.1
76.3
20.5
23.2
15.6
31.9
21.7
28.6
Hepatitis C (newly acquired)‡
6.3
0.3
1.7
0.0
2.6
3.1
2.1
7.0
1.7
Hepatitis C (unspecified)§
47.2
48.0
77.9
57.0
23.7
47.6
36.1
40.6
44.6
Hepatitis D
0.0
0.3
0.0
0.3
0.0
0.0
0.3
0.0
0.2
Gastrointestinal diseases
Botulism
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
Campylobacteriosis
140.5
NN
116.1
128.2
98.9
151.2
113.2
114.6
118.3
Cryptosporidiosis
4.2
4.9
36.5
18.0
16.3
7.8
12.1
13.8
11.5
Haemolytic uraemic syndrome
0.0
0.1
1.7
0.1
0.0
0.0
0.1
0.0
0.1
Hepatitis A
1.0
0.7
0.0
0.7
0.0
0.0
1.1
0.3
0.7
Hepatitis E
1.0
0.9
0.0
0.1
0.0
0.0
0.1
0.0
0.3
Listeriosis
0.0
0.4
0.0
0.2
0.5
0.0
0.6
0.0
0.3
STEC,VTEC||
0.0
0.5
0.0
0.8
2.6
0.0
0.2
0.0
0.6
Salmonellosis
74.4
57.4
240.5
112.7
78.3
32.7
62.0
56.0
72.7
Shigellosis
1.0
1.7
39.8
3.0
0.7
0.0
7.7
2.4
3.8
Typhoid fever
0.0
0.5
1.7
0.1
0.2
0.0
0.3
0.6
0.4
Quarantinable diseases
Cholera
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
Human pathogenic avian influenza in humans
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Plague
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rabies
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Severe acute respiratory syndrome
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Smallpox
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Viral haemorrhagic fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Yellow fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Sexually transmitted infections
Chlamydial infection¶,**
319.8
305.6
1,313.5
437.3
337.6
376.5
336.4
449.4
370.0
Donovanosis
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Gonococcal infection**
29.4
65.8
819.3
63.8
52.7
8.6
48.7
87.6
68.6
Syphilis – congenital
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Syphilis < 2 years duration**
5.2
7.9
21.6
8.2
1.2
2.3
10.1
5.1
7.7
Syphilis > 2 years or unspecified duration§,**
9.4
5.1
16.6
5.2
7.2
2.3
15.8
1.9
7.7
Vaccine preventable diseases
Diphtheria
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Haemophilus influenzae type b
0.0
0.1
0.0
0.2
0.0
0.0
0.1
0.2
0.1
Influenza (laboratory confirmed)
71.3
55.2
79.6
127.2
121.4
63.1
61.3
76.2
79.0
Measles
0.0
0.4
1.7
2.7
1.2
0.0
1.2
1.6
1.2
Mumps
1.0
0.9
0.0
1.3
0.2
0.8
0.2
0.3
0.7
Pertussis
47.2
22.6
29.9
28.1
24.9
11.7
53.6
59.0
35.8
Pneumococcal disease (invasive)
4.2
7.0
11.6
4.9
6.9
9.4
7.5
8.3
6.9
Poliomyelitis
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rubella
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
Rubella – congenital
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Tetanus
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Varicella zoster (chickenpox)
7.3
NN
38.1
3.0
18.4
4.7
13.5
18.9
11.7
Varicella zoster (shingles)
15.7
NN
96.2
0.9
112.5
52.2
26.3
52.4
33.8
Varicella zoster (unspecified)
67.1
NN
1.7
110.0
14.6
21.8
58.9
45.9
65.3
Vectorborne diseases
Arbovirus infection (NEC)
0.0
0.1
0.0
0.6
0.0
0.0
0.1
0.0
0.2
Barmah Forest virus infection
0.0
3.2
19.9
10.8
0.0
0.0
0.2
2.2
3.7
Dengue virus infection
8.4
6.4
29.9
8.9
5.0
4.7
0.3
21.4
7.2
Japanese encephalitis virus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Kunjin virus infection††
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Malaria
3.1
1.6
1.7
1.8
0.5
0.8
0.2
2.4
1.3
Murray Valley encephalitis virus infection††
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Ross River virus infection
2.1
11.4
160.9
59.4
3.6
3.1
1.7
40.3
22.5
Zoonoses
Anthrax
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Australia bat lyssavirus
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Brucellosis
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
Leptospirosis
0.0
0.1
0.0
2.4
0.0
0.0
0.0
0.2
0.5
Lyssavirus (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Ornithosis
0.0
0.1
0.0
0.0
0.0
0.0
0.2
0.0
0.1
Q fever
0.0
1.8
0.0
5.7
1.2
0.0
0.2
0.3
1.9
Tularaemia
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Other bacterial diseases
Legionellosis
0.0
1.0
1.7
1.6
2.6
1.6
2.4
3.5
1.9
Leprosy
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.3
0.1
Meningococcal infection‡‡
1.0
0.7
0.0
0.9
1.0
0.0
0.4
1.0
0.7
Tuberculosis
5.2
5.5
10.0
2.9
2.4
0.0
8.2
4.8
5.2

Top of page

In this section

CDI Search

Search Communicable Diseases Intelligence

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now

Communicable Diseases Surveillance